Wednesday, October 16
Summit Day 1
Summit Day 1
| 6:00 am – 8:00am | REGISTRATION and BREAKFAST NETWORKING |
| 6:45am – 7:00am | Opening Comments: Leaders Lead Markets Follow Burt Zweigenhaft, PhD, DLitt, Co-Founder & Executive Director, AVBCC; EVP, Corporate, FFF Enterprises |
| 7:00am – 7:50am | Oncology as a Rare Disease: Does it Change How We Value Oncology Therapies? Moderator: Jason Spangler, MD, MPH, FACPM, CEO, The Center for Innovation & Value Initiative Faculty: Beth Hamilton, VP, Global Oncology Market Access and Pricing, AstraZeneca Zubair Ansari, MHA, Executive Director, Cancer Support Community Gebra Cuyun Carter, MPH, PhD, Senior Director, Health Economics & Outcomes Research, Exact Sciences |
| 7:00am – 7:50am | Shifting Incentives on Generics to Benefit the Health Care System Moderator: William McGivney, PhD, Manaing Partner, McGivney Global Services Faculty: Philip Sclafani, Partner, PwC Matt Erick, Chief Commercial Officer Advanced Markets, Biocon Biologics Ryan Juhring, PharmD, Research Director, Formulary Insights in partnership with Petauri Laura Bray, Chief Change Maker, Angels for Change Gina Guinasso, JD, Former President, CivicaScript |
| 7:00am – 7:50am | Impact of FDA Final Rule Regulating Lab Diagnostic Tests on Cancer Care Moderator: Lauren Feldman, Head of Market Access, Precision Medicine, ADVI Faculty: Lucy Langer, MS, MD, National Medical Director, Oncology and Genomics, UnitedHealthcare Stan Skrzypzcak, MS, MBA, Managing Partner, 5Prime Life Science Consulting, Inc. Julie Wiedower, PhDc, CGC, Senior Director, Medical Affairs, Managed Care, Guardant Health Christine Bump, JD, MPH, Principal, Penn Avenue Law & Policy |
| 7:00am – 7:50am | The Evolving Economic Impact on Care Delivery Moderator: Aaron McKeon-Fish, Partner, The Dedham Group Faculty: Alex Santini, SVP & Head, Global and US Market Access, Arvinas Eduardo Schur, Commercial and R&D Lead Health Sciences & Wellness, Partner, E&Y Scott Howell, MD, Former US Chief Strategy Officer, Novartis; Co-founder, Synapse Sciences Rory Davies, PharmD, VP, Formulary Insights (in partnership with Petauri) |
| 8:00am __ 8:50am | Cancer Care Ecosystem: A Look at the Important Trends and the Forecast Ahead Moderator: Barbara McAneny, MD, Past President, American Medical Association; Co-Chair, ONCare Alliance; CEO, New Mexico Cancer Center Faculty: Bruce Pyenson, FSA, MAAA, Principal & Consulting Advisory, Milliman Arda Ural, MSc, MBA, PhD, Americas Sector Leader, Ernst & Young LLP (EY) Sarah Alwardt, Avalere, PhD, President, Avalere Scott Biggs, Director, Supplier Services, IQVIA |
| 8:00am __ 8:50am | Value-Based Care: Is it Evolution or a Revolution Moderator: Linde Finsrud Wilson, Managing Partner, HealthQuest Advisors Faculty: Mike Fazio, Head of Value-Based Care, Navista Barry Russo, MBA, CEO, The Center for Cancer and Blood Disorders Alti Rahman, MHA, MBA, CSSBB, Chief Strategy Innovation Officer, American Oncology Network, (AON) Joel White, President & CEO, Horizon Government Affairs Basit Chaudhry, MD, PhD, Founder, Tuple Health Jason Spangler, MD, MPH, FACPM, CEO, The Center for Innovation & Value Initiative |
| 8:00am __ 8:50am | Evolution of Clinical Trials So What’s Happening? Moderator: Howard Kraft, SVP, Market Engagement, XO Health Faculty: Mark Lee, MD, PhD, Co-Founder, NPower Sibel Blau, MD, President & CEO, ONCare Alliance/Exigent Research Elizabeth Garrett-Mayer, PhD, FSCT, VP, Center for Research and Analytics, ASCO Chris Popple, Consultant, IntrinsiQ Specialty Solutions John Doyle, DrPH, President & Global Head, Consulting, Fortrea Debra Wong, MD, Vice President of Development & Integration of Clinical Strategy, AccessHope |
| 8:00am __ 8:50am | Cancer Moonshot and Update on the Orbit Moderator: Greg Simon President, Simonovation, LLC; Former Executive Director, White House Cancer Moonshot Task Force Faculty: Anabella Aspiras, MPA, RN, BSN, Assistant Director, Cancer Moonshot Engagement |
| 9:00am __ 9:50am | Inflation Reduction Act: What’s Next for Oncology, Hematology, and Cell and Gene Therapy, The Producer’s View Moderator: Alicia Silver, Head of Cell and Gene Therapy Market Access, ADVI Health Faculty: Katheryne Richardson, VP, Global Pricing and Health Systems Analytics, Bristol Myers Squibb Angela Riemer, Vice President & Head, U.S. Business Policy & Public Affairs, Pfizer John Doyle, DrPH, President & Global Head, Consulting, Fortrea John Hughes, Executive Director, Federal Policy and Government Relations, Merck David Senior, MPH, SVP, Market Economics, Cencora |
| 9:00am – 9:50am | Bispecific Antibodies: Where Do We Stand, and What Are the Barriers to Community Adoption Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Tony Lin, PharmD, RPh, Interim Chief Medical Partner – Oncology & Hematology, USMA; Hematology (Lymphoma Portfolio) Disease Area Lead, Genentech Lavi Kwiatkowsky, Founder & CEO, Canopy Courtney Morrow, PhD, Director, Healthcare Quality Strategy, Johnson & Johnson Innovative Medicine Barry Brooks, MD, MBA, Medical Director GPO Services, McKesson Specialty Health |
| 9:00am – 9:50am | What’s Really Happening with Pharmacy Reimbursement? A Look at 2024 PBM Policy Changes Through Data Moderator: Tesh Khullar, MBA, Founder & CEO, Prism TPO Faculty: Jeff Patton, MD, CEO, OneOncology & Executive Chairman of the Board, Tennessee Oncology Barbara McAneny, MD, Past President, American Medical Association; Co-Chair, ONCare Alliance; CEO, New Mexico Cancer Center Daniel Virnich, MD, MBA, FACHE, The Oncology Institute for Hope and Innovation Mel Davies, Oregon Oncology Specialists |
| 9:00am – 9:50am | The Practice Analytics Imperative: Better Measurement for Better Management Moderator: Nina Chavez, MBA, VP, Strategic Partnerships & Alliances, Flatiron Health Faculty: Anish Arora, VP, Product Management, Navista V. Scott Morris, VP, President & GM, IntrinsiQ Specialty Solutions Cory Wiegert, COO, Integra Connect Lalan Wilfong, Senior Vice President Value Based Care, Thyme Care |
| 10:00am – 10:50am | CMS, CMMI, and Cancer Care: What Does the Future Hold Moderator: Hillary Cavanagh, Sr. Director, PhRMA Faculty: Alexandra Chong, PhD, EOM Team Lead, CMS Innovation Center Ellen Lukens, Deputy Director, Center for Medicare & Medicaid Innovation |
| 10:00am – 10:50am | Is Medicare Advantage Still Financially Viable for Oncology Providers? Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Daniel Virnich, MD, MBA, FACHE, CEO, The Oncology Institute of Hope and Innovation Rhonda Henschel, MBA, SVP, Payer and Care Transformation, McKesson Milena Sullivan, Managing Director of Policy, Avalere Todd Stevens, MBA, Chief Operating Officer, OneOncology |
| 10:00am – 10:50am | Biosimilars: How Are We Really Doing: Is it Survival or Extinction? Moderator: Kathy Oubre, CEO, Pontchartrain Cancer Center Faculty: Sean McGowan, MBA, VP, Biosimilars & Branded Oncology, Amneal Scott Dulitz, MBA, CEO, Mercalis Barry Brooks, MD, MBA, Medical Director GPO Services, McKesson Specialty Health Dominick Oliverio, VP, Oncology Biosimilars and US Portfolio Marketing Lead, Pfizer |
| 10:00am – 10:50am | Digital Healthcare Tools: How to Impact Care, Outcome, and Value Moderator: Stan Kachnowski, PhD, MPA, Director, Digital Health Program, Columbia Business School Faculty: Christopher Merlan, Chief Digital Officer & EVP, ASCO Dan Nardi, CEO, Reimagine Care Andrew Norden, MD, MPH, Chief Medical Officer, OncoHealth Marianne Gandee, VP, Oncology Patient Solutions & Alliances, Pfizer Ben Freeberg, Managing Partner, Oncology Ventures Dave Miller, MD, MS, Founder & CEO, mPATH |
| 11:00am – 11:50am | Have Oncology Providers Moved on Beyond OCM and EOM? Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Barbara McAneny, MD, Past President, American Medical Association; Co-Chair, ONCare Alliance; CEO, New Mexico Cancer Center Susan Escudier, MD, FACP, VP, Value Based Care and Quality Programs, Texas Oncology Stephen “Fred” Divers, MD, Chief Medical Officer, AON Scotty Pepper, MSM, VP Operations, Population Health, Integra Connect Jeff Patton, MD, CEO, OneOncology & Executive Chairman of the Board, Tennessee Oncology |
| 11:00am – 11:50am | Artificial Intelligence and the Future Ahead for Providers Moderator: Alti Rahman, MHA, MBA, CSSBB, Chief Strategy and Innovation Officer, American Oncology Network, LLC (AON) Faculty: Brigham Hyde, PhD, CEO, Atropos Cory Wiegert, Chief Operating Officer, Integra Connect V. Scott Morris, VP, President & GM, IntrinsiQ Specialty Solutions David Holecek, Co-Founder & COO, Wild Type Advocates Nini Wu, MD, MBA, Chief Medical & Development Officer, Navista |
| 11:00am – 11:50am | Yes, Virginia, We Do Need National Quality Measures for Cancer Diagnosis and Treatment Moderator: John Fox, MD, MHA, Senior Medical Director for the Americas, Market Access, Illumina Faculty: Lucy Langer, MS, MD, National Medical Director, Oncology and Genomics, UnitedHealthcare Brian Bourbeau, MBA, Division Director, Quality and Care Innovation, American Society of Clinical Oncology James Hamrick, MD, MPH, VP, Clinical Oncology, Flatiron Health Lalan Wilfong, MD, Senior Vice President Value Based Care, Thyme Care Erin Crum, MPH, Senior Director, Quality Strategy and Innovation, McKesson |
| 11:00am – 11:50am | 340B Contract Pharmacies: Legal Battle and Litigation Review Moderator: Ted Slafsky, Publisher and CEO The 340B Report Faculty: Bill Sarraille,Adjunct Professor, University of Maryland Francis King Carey School of Law Barbara Straub Williams, JD, Principal, Powers Pyles Sutter & Verville PC Jennifer Lockwood, MBA, ACHE, CEO & Founder, Ravin Consultants |
| 12:00pm– 12:50pm | Lunch |
| 1:00pm – 1:50pm | Improving Collaboration Between Oncology Practices and the PBM industry Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Debra Patt, MD, PhD, MBA, Executive Vice President, Policy and Strategic Initiatives, Texas Oncology Stephen “Fred” Divers, MD, Chief Medical Officer, AON Yen Nguyen, PharmD, Executive Director of Pharmacy, Oncology Consultants Erin Satterwhite, CEO, Optum Specialty Pharmacy Sunil Budhrani, MD, MPH, MBA, Chief Innovation & Medical Officer, Capital Rx Ross Hoffman, MD, CMO, FFF Enterprises |
| 1:00pm __ 1:50pm | Cancer Care for the Rest of Us; Can We Do Precision Medicine in the Middle of America Moderator: Ira Klein, MD, MBA, FACP, VP, Medical Affairs, Payer Relations, Tempus Labs Inc. Faculty: Kurt Oettel, MD, MBA, FACP, FASCO, Cancer Center Director, Gundersen Health System Barbara McAneny, MD, Past President, American Medical Association; Co-Chair, ONCare Alliance; CEO, New Mexico Cancer Center Alti Rahman, MHA, MBA, CSSBB, Chief Strategy and Innovation Officer, American Oncology Network, LLC (AON) Sybil Green, JD, RPh, MHA, Diversity and Inclusion Officer, American Society of Clinical Oncology Thomas Stricker, MD, PhD, Medical Director, Precision Medicine, OneOncology Lorraine Brisbin, MS, MLS, VP, Precision Medicine, Texas Oncology |
| 1:00pm __ 1:50pm | The Evolving Role of Clinical Pathways in Value-Based Care Moderator: Sophia Tan, PhD, Partner, The Dedham Group Faculty: Courtney Morrow, PhD, Director, Healthcare Quality Strategy, Johnson & Johnson Innovative Medicine David Jackman, MD, Dana Farber Cancer Institute Lalan Wilfong, MD, Senior Vice President Value Based Care, Thyme Care Lucy Langer, MS, MD, National Medical Director, Oncology and Genomics, UnitedHealthcare |
| 1:00pm __ 1:50pm | Oncology Nurse Navigation Funding and the Future of Sustainability Paths Moderator: Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Editor in Chief Journal of Oncology Navigation & Survivorship® Faculty: Andi Dwyer, BS, Program Director, Colorado Cancer Screening Program Linda Fleisher, PhD, MPH, Research Professor, Fox Chase Cancer Center Rani Khetarpal, MBA, CEO, NavPoint Health Lani Alison, BSN, MS, PCMH-CCE, VP, Quality & Value Transformation, Integra Connect |
| 2:00pm __ 2:50pm | Tension and Fractures Between Academic and Community Practices Moderator: David Johnson, MD, MPH, Clinical Operating Partner, Rubicon Founders Faculty: Harlan Levine, MD, President, Health Innovation and Policy, City of Hope Ray Page, DO, Senior Advisor, Center for Cancer and Blood Disorders Sibel Blau, MD, President & CEO, ONCare Alliance/Exigent Research Asmita Mishra, MD, MBA, Medical Director of Payer Strategies, Associate Professor in the Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center Yale Podnos, MD, MPH, FACS, CMO, The Oncology Institute |
| 2:00pm __ 2:50pm | Smart-Intelligent Supply Channels: Are Producers to Providers the Future? Moderator: Bob Charles, Co-Founder, Principal, MedTec Rx Faculty: Pramod John, PhD, CEO, Vivio Health a Public Benefit Corporation AJ Loiacono, CEO, Capital Rx |
| 2:00pm __ 2:50pm | Wall Street Economic View on Healthcare Post-Election Moderator: Lisa Gill, Managing Director, JP Morgan Faculty: Amir Dan Rubin, CEO & Founding Managing Partner, Healthier Capital Eric Mattson, Partner, Excellere Partners |
| 2:00pm __ 2:50pm | Self-Insured Employer Market on the Future of Cancer Care Moderator: Robert Baird, RN, MSA, President, National Cancer Treatment Alliance Faculty: François de Brantes, MBA, MS, EVP Network Performance, XO Health Sally Welborn, Advisor, Welborn Advisory Services Kiana Mehring, MBA, Senior Director, Strategic Partnerships – Managed Care, Florida Cancer Specialists & Research Institute Shawn Gremminger, President and CEO, National Alliance of Healthcare Purchaser Coalitions |
| 3:00pm __ 3:50pm | Executive Leadership Roundtable Moderator: Marc Samuels, MPH, JD, CEO, ADVI Health Leadership Panel: Wendy Bartie, Senior Vice President, US Oncology and Hematology, BMS Chris Mancill, MA, Senior Vice President & Head, US Market Access, AstraZeneca Kara Reheis, MBA, VP, US Marketing, Daiichi Sankyo Axel Hoos, MD, PhD, Former CEO, Scorpion Therapeutics |
| 3:00pm __ 3:50pm | Oncology Pipeline Forecast Moderator: William McGivney, PhD, Managing Partner, McGivney Global Advisors Faculty: Kelly McAuliff, PharmD, BCOP, CSP, Senior Clinical Manager, Specialty Manufacturer Services, CVS Specialty Cheryl Ann Allen, MBA, BS Pharm, Founding Partner, Curatio Scientia Advisors Jeffrey Bockman, PhD, Expert Advisor & EVP, Oncology; Head of Oncology Center of Excellence, Lumanity Simone Ndujiuba, PharmD, BCOP, Director, Clinical Strategy and innovation, Oncology, Prime Therapeutics |
| 3:00pm __ 3:50pm | HUB Services and a Look at the Future Models Moderator: Douglas Bock, MBA, Partner, Archbow Faculty: Marianne Gandee, VP, Oncology Patient Solutions & Alliances, Pfizer Ben Stormer, Chief Commercia Officer, Annexus Health Jennifer Millard, MBA, VP, Integrated Patient Support Services, IQVIA Lori Schneider, Oncology Operations Manager, Green Bay Oncology Sumner Madden, Principal, Intrinsic Value Services |
| 3:00pm __ 3:50pm | Emerging Challenges and Opportunities within Ambulatory Drug Infusion Moderator: Jorge J. García, PharmD, MS, MHA, MBA, FACHE, Assistant Vice President – System Oncology, Infusion and Investigational Drug and Research Pharmacy Services, Baptist Health South Florida Faculty: Kenneth Komorny, PharmD, BCPS, VP, Chief Pharmacy Officer, Moffitt Cancer Center Scott Freeswick, MS, PharmD, VP & Chief Pharmacy Officer, Memorial Sloan Kettering Cancer Center Anthony Boyd, PharmD, BCPS, Head of Oncology Pharmacy Services, Cleveland Clinic Wafa Samara, PharmD, VP & Chief Pharmacy Officer, City of Hope |
| 4:00pm __ 4:50pm | Election 2024: A Tale of Two Futures Moderator: Lindsay Greenleaf, Solution Leader and Head, Policy, ADVI Health Faculty: John McManus, Owner, The McManus Group Miranda Franco, MA, Senior Policy Advisor, Holland & Knight John O’Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council; Former Senior Advisor to Secretary of US Department Health and Human Services Tracy Spicer, Avenue Solutions |
| 4:00pm __ 4:50pm | Risk and Re-Insurance Partners in the Future of Healthcare Moderator: Bruce Pyenson, FSA, MAAA, Milliman Faculty: William Shrank, MD, Former CMO Humana, Partner, Andreessen Horowitz Scott Kornhauser, Executive VP, KlearTrust Brian Kern, Esq., CEO, Deep Risk Management Greg Simon President, Simonovation, LLC; Former Executive Director, White House Cancer Moonshot Task Force Vince Micucci, National Director of Value Based Healthcare Solutions, Alliant Insurance Services Tay Salimullah, Former Chief Access Commercial Officer, Novartis Gene Therapies; Principle, Renovamen Advisory LLC |
| 4:00pm __ 4:50pm | Cell and Gene Therapy: Update on the Science and Development Moderator: Phil Cyr, Senior Vice President, Precision Value & Health Faculty: Alfred Slanetz, MS, PhD, President & CEO, Geneius Biotechnology Doug Danison, Head of Commercial Cell and Gene Therapy Unit, Bayer Magdalene Pedersen, VP Cell Therapy Strategy and Operations, Bristol Myers Squibb Chris Jeffers, JD, Co-Founder & Member, BioForge David Peritt, PhD, MSc, Founder & CSO, Lupagen Jason Foster, MBA, CEO & Executive Director, ORI Biotech |
| 4:00pm __ 4:50pm | Prior Authorizations and the Impact of Artificial Intelligence: Increasing or Decreasing the Complexity of Process Moderator: Douglas Bock, MBA, Partner, Archbow Faculty: Bill Dupere, MBA, VP, Market Access Solutions, Mercalis Marilyn Heine, MD, American Medical Association Trustee Ross Hoffman, MD, CMO, FFF Enterprises Ankit Jain, CEO, Infinitus AI |
| 5:00pm __ 5:50pm | Keynote with Scott Gottlieb, MD Thoughts from one of the most influential people in healthcare today. Moderator: Jayson Slotnik, JD, Health Strategies Group Faculty: Scott Gottlieb, MD, Former Commissioner, FDA |
| 5:00pm – 5:50pm | Pharmacists and Their Impact and Role in Value-Based Care Moderator: Tamiko Yamatani, RPh, VP of Customer Operations, House Rx Faculty: Brooke Looney, PharmD, CSP, Clinical Pharmacist, Oncology Lead, Vanderbilt University Medical Center Charlotte Yum, PharmD, AAHIVP, CSP, Oncology Specialty Pharmacist, House Rx Ray Bailey RPH, Former Pharmacy Director Florida Cancer Specialists James Gilmore, PharmD, Chief Pharmacy and Clinical Services Officer, American Oncology Network |
| 5:00pm – 5:50pm | Oncology’s Value-Based Revolution: Overcoming Barriers to Align Price with Outcomes Moderator: Scott Howell, MD, Former US Chief Strategy Officer, Novartis; Co-founder, Synapse Sciences Faculty: Scott Kornhauser, Executive VP, KlearTrust John Doyle, DrPH, President & Global Head, Consulting, Fortrea Jim Clement, MHA, PartnerCOEUS Ross Hoffman, MD, CMO, FFF Enterprises |
Thursday, October 17
Summit Day 2
AVBCC “WE MUST DO BETTER”
Summit Day 2
AVBCC “WE MUST DO BETTER”
| 7:00am – 8:00am | OPENING DAY REGISTRATION AND BREAKFAST |
| 7:30am – 8:00am | Opening comments and a review of the agenda. Burt Zweigenhaft, PhD, DLitt, Co-Founder, AVBCC |
| 8:00am – 8:50am | Provider Leadership Moderator: Kathy Oubre, CEO, Pontchartrain Cancer Center Faculty: Nicolas Ferreyros, Managing Director Policy and Advocacy and Communications, COA Alyssa Schatz, MSW, VP, Policy & Advocacy, NCCN Cliff Hudis, MD, FACP, FASCO, CEO, ASCO |
| 8:00am – 8:50am | Is Drug Compensation for Providers at Risk/Sustainable in the Future? Moderator: Barry Brooks, MD, MBA, Medical Director GPO Services McKesson Specialty Health Faculty: Jason Spangler, MD, MPH, FACPM, CEO, The Center for Innovation & Value Initiative Debra Patt, MD, PhD, MBA, Executive Vice President, Policy and Strategic Initiatives, Texas Oncology Neal Masia, PhD, Co-Founder & CEO, EntityRisk Stephen “Fred” Divers, MD, Chief Medical Officer, AON Michael Sherman, MD, Former CMO, Harvard Pilgrim Health Care and Point32Health; Venture Partner, RA Capital Management |
| 8:00am – 8:50am | Stakeholder Priorities and Paradigms of Value-Based Cancer Care: Research and Realities Among Patients, Providers, and Payers Moderator: Julie Wiedower, PhDc, CGC, Senior Director, Medical Affairs, Managed Care, Guardant Health Faculty: Casey Allen, MD, Div. Surgical Oncology, Institute of Surgery, Allegheny Heath Network Matt Fickie, MD, Senior Medical Director, Highmark Joelle Fathi, DNP, RN, ARNP, FAAN, Chief Healthcare Delivery Officer, GO2 Foundation for Lung Cancer Magdalena Jurkiewicz, MD, PhD, MPH, Medical Director, MolDX; Chief Medical Officer, Palmetto GBA |
| 8:00am – 8:50am | Navigating Multiple Formularies Part B/D and Impact on Practices, Payers, and Patients Moderator: Chris Marcum, PharmD, Executive Director, System Pharmacy Business and Strategy, City of Hope Faculty: James Gilmore, PharmD, Chief Pharmacy and Clinical Services Officer, American Oncology Network Marlo Blazer, PharmD, BCOP, Director of Pharmacy, Columbus Oncology & Hematology Tracy Margiott, Principal and Consulting Actuary, Milliman Rory Davies, PharmD, VP, Formulary Insights (in partnership with Petauri) |
| 9:00am – 9:50am | Building Better Alignment Cancer Care Providers and Primary Care Groups Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Brad Diephuis, MD, MBA, Chief Business Officer, Thyme Care Scott Belsky, SVP Population Health, Oak Street Health Alti Rahman, MHA, MBA, CSSBB, Chief Strategy and Innovation Officer, American Oncology Network, LLC (AON) Elizabeth Liebow, MS, Principal, Center for Advanced Oncology, ECG Management Consultants |
| 9:00am – 9:50am | Buy-Side Sell-Side Investors Views on Oncology Care Markets, Payers, Providers, and Producers Moderator: Ipsita Smolinski, Managing Director, Capital Street Faculty: David Deuchler, CFA, Managing Director, Gilmnartin Group Matt Cohen, MD, Portfolio Manager, JP Morgan Chase Eric Mattson, Partner, Excellere Partners Jonathan Fassberg, MBA, Co-Founder and Managing Partner, astr partners |
| 9:00am – 9:50am | Pharmaceutical Litigation Summary: Where We Are and What to Expect Moderator: Nicolas Ferreyros, Managing Director Policy and Advocacy and Communications, COA Faculty: Jonathan Levitt, Esq., Founding Partner, Frier Levitt Bradley A. Wasser Esq., Duane Morris Rujul Desai, Partner, Covington & Burling Jason Silberberg, Esq., Partner, Frier Levitt |
| 9:00am – 9:50am | ASCO Certified, Patient Centered Care Transformation Moderator: Stephen Grubbs MD, FASCO, VP, Care Delivery, ASCO Faculty: Kevin Svoboda, CEO, Central Georgia Cancer Care, PC Kasey Bowden, MSN, FNP, AGACNP, Associate Professor, Medicine-Hospital Medicine, University of Colorado Ronda Bowman, MHA, RN, OCN, Sr. Director, ASCO Certification Programs, ASCO Barry Russo, MBA, CEO, The Center for Cancer and Blood Disorders |
| 10:00am – 10:50am | Healthcare as an Election Issue: What Happens in 2025? Moderator: John O’Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council; Former Senior Advisor to Secretary of US Department Health and Human Services Faculty: Joseph Grogan, JD, USC Schaeffer Institute |
| 10:00am – 10:50am | Data Exchange Infrastructure: A Super-Highway or Traffic Jam on the Washington Beltways Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Cory Wiegert, Chief Operating Officer, Integra Connect Scott Kornhauser, Executive VP, KlearTrust James Hamrick, MD, VP Clinical Oncology, Flatiron Health Suzanne Belinson, PhD, MPH, VP, Commercial Markets, Tempus |
| 10:00am – 10:50am | Have Clinical Pathways Outlived Their Usefulness in the World of AI? Moderator: Atul Dhir, MD, CEO, Principia Health Faculty: Andrew Hertler, MD, FACP Chief Medical Officer, Evolent Health New Century Andrew Norden, MD, MPH, Chief Medical Officer, OncoHealth John Burke, MD, Chair, US Oncology Pathways Taskforce Kiana Mehring, MBA, Senior Director, Strategic Partnerships – Managed Care, Florida Cancer Specialists & Research Institute Ed Rodgers, Network Development Director, Elsevier ClinicalPath |
| 10:00am – 10:50am | Meaningful Measure Development for Value Based Contracts Moderator: Brian Bourbeau, MBA, Division Director, Quality and Care Innovation, American Society of Clinical Oncology Faculty: John Cox, DO, MBA, MACP, FASCO, Medical Oncologist, Texas Marc Watrous, PhD, Managing Partner, @A3Access; Former Senior Vice President, Managed Care and Customer Operations, Genentech Miranda Lam, MD, MBA, Assistant Professor of Radiation Oncology, Harvard Medical School; Radiation Oncologist, Dana-Farber Cancer Institute Ron Kline, MD, Chief Medical Office, Quality Measurement and Value-Based Incentives Group at CCSQ/CMS John Fox, MD, MHA, Senior Medical Director for the Americas, Market Access, Illumina |
| 11:00am – 11:50am | Is EOM Working for Oncology Providers? Moderator: Hillary Cavanagh, Senior Director, PhRMA Faculty: Paul Thurmes, MD, President, Minnesota Oncology Hematology Susan Sabo Wagner, MSN, RN, OCN, NEA-BC, VP of Clinical Innovation, American Oncology Network Aaron Lyss, Senior Director, Payment and Policy Innovation, OneOncology Glenn Balasky, Executive Director, Rocky Mountain Cancer Centers Sibel Blau, MD, President & CEO, ONCare Alliance/Exigent Research Terrilll Jordan, BS, JD, Regional Cancer Care Associates |
| 11:00am – 11:50am | APPs and Improving Access for Cancer Care Patients Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Yale Podnos, MD, MPH, FACS, Chief Medical Officer, The Oncology Institute Debra Patt, MD, PhD, MBA, Executive Vice President, Policy and Strategic Initiatives, Texas Oncology Wendy Vogel, MSN, FNP, AOCNP, Executive Director, Advanced Practitioner Society for Hematology nd Oncology (APSHO) |
| 11:00am – 11:50am | Utilizing Multi-Omic Data for Impacting Quality and Cost of Care Moderator: Stan Skrzypczak, MS, MBA, Managing Partner, 5Prime Life Science Consulting, Inc. Faculty: Mark Hiatt, MD, MBA, MS, Senior Vice President of Market Access & Strategy, BostonGene; Chief Medical Officer, RadSite Ira Klein, MD, MBA, FACP, VP, Medical Affairs, Payer Relations, Tempus Labs Inc. Julie Wiedower, PhDc, CGC, Senior Director, Medical Affairs, Managed Care, Guardant Health Anna Ogloblina, PhD, Senior Director, Market Access & Product Management, BostonGene |
| 11:00am – 11:50am | Oncology at Home: How Does This Option Fit into the Treatment Paradigm Moderator: Steven Peskin, MD, MBA, MACP, Associate Clinical Professor, Robert Wood Johnson School of Medicine Faculty: Pallav Mehta, MD, Medical Director, Reimagine Care Barry Russo, MBA, CEO, The Center for Cancer and Blood Disorders Harlan Levine, MD, President, Health Innovation and Policy, City of Hope Pete Scruggs, Founder, benefitSMART Elizabeth Liebow, MS, Principal, Center for Advanced Oncology, ECG Management Consultants |
| 12:00pm – 12:50pm | Lunch |
| 1:00pm – 1:50pm | Independence or Consolidation: Two Paths Forward for Oncology Providers Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Todd Stevens, MBA, Chief Operating Officer, OneOncology Sibel Blau, MD, President & CEO, ONCare Alliance/Exigent Research Todd Schonherz, CEO, AON Jeremy Castle, MBA, Chief Operations Officer, The Oncology Institute |
| 1:00pm – 1:50pm | Security & Resiliency – The New Mandate for Revenue Cycle IT Moderator: Brian Gockerman, CEO, Unlimited Systems Faculty: Dave Wilcoxson, Director Channel Sales, Availity Jim Musslewhite, MBA, MSF, CEO & Owner, Oncology Convergence Jeff Hunnicutt, CEO, Highlands Oncology Group |
| 1:00pm – 1:50pm | Legal, Regulatory and Contractual Issues When Structuring Value-Based Agreements Moderator: Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies Faculty: Jesse Dresser, Esq., Partner, Frier Levitt Margaux Hall, Partner, Ropes & Gray Amy Bassano, Managing Director, Medicare, Health Management Associates Lauren Moldawer, Member, Mintz Levin |
| 1:00pm – 1:50pm | Employers Struggling with Healthcare Costs Increasing Focus on Cancer Care Moderator: Art Taft, MBA, MEng, Managing Director, Medworks Consulting, LLC Faculty: Monte Masten, MD, Chief Medical Officer, Marsh McLennan Lisa Comerose, RN, BSN, MBA, VP, National Clinical Mgmt. Consulting, Marsh McLennan Ashley Bacot, Health Plan Architect, Rosen Health Shawn Gremminger, President and CEO, National Alliance of Healthcare Purchaser Coalitions |
| 2:00pm – 2:50pm | Improving Collaboration Between Oncology Provider and Payers Moderator: Michael Kolodziej, MD, Chief Medical Officer, Canopy Faculty: Lucy Langer, MS, MD, National Medical Director, Oncology and Genomics, UnitedHealthcare Rhonda Henschel, MBA, SVP, Payer and Care Transformation, McKesson Daniel Virnich, MD, MBA, FACHE, The Oncology Institute for Hope and Innovation Mona Chitre, PharmD, Chief Pharmacy Officer & President, Pharmacy Solutions, Lifetime Healthcare Companies Christopher Windham, MD, MHCM, MPHM, Physician Executive National Operations, Lumeris |
| 2:00pm – 2:50pm | Are We Properly Preparing: The Post-ASP World after 2028 Moderator: Kent Rogers, MBA, Venture Partner, ARCH Venture Partners Faculty: Gina Guinasso, JD, Former President, CivicaScript Matt Fickie, MD, Senior Medical Director, Highmark Ross Hoffman, MD, CMO, FFF Enterprises Marc Watrous, PhD, Head of North America Commercial Transformation and New Product Launches, Sanofi |
| 2:00pm – 2:50pm | How is this Year’s Steep Drop in Investor and Large-Scale Strategics Support for Cell and Gene Therapies Impacting Commercialization Models in 2024? Moderator: Amy DuRoss, Senior Advisor, Frazier Healthcare Partners Faculty: Joe DePinto, Head of Cell Gene Advanced Therapies, McKesson Lung-I Cheng, VP, Cell and Gene Therapy Line Service Line, Cencora Kristi Jones, CEO, NexImmune Tay Salimullah, Former Chief Access Commercial Officer, Novartis Gene Therapies; Principle, Renovamen Advisory LLC Sarah Pitiluck, MSc, Founder, SP Consulting, LLC |
| 2:00pm – 2:50pm | Oncology Clinical Pathways Moderator: Lee Blansett, MBA, EVP, Market Access Insights, HMP Global Faculty: Andrew Hertler, MD, FACP Chief Medical Officer, Evolent Health New Century Mary Ichiuji, MD, Beacon, National Physician Lead, Permanente Medical Group Barry Russo, MBA, CEO, The Center for Cancer and Blood Disorders Ed Rodgers, Network Development Director, Elsevier ClinicalPath Chris Linkimer, General Manager, Condition-Specific Solutions, EviCore by Evernorth Barbara McAneny, MD, Past President, American Medical Association; Co-Chair, ONCare Alliance; CEO, New Mexico Cancer Center |
| 3:00pm – 3:50pm | Oncology Drug Trend and Forecast Moderator: Cheryl Ann Allen, MBA, BS Pharm, Founding Partner, Curatio Scientia Advisors Faculty: Doug Long, Vice President, Industry Relations, IQVIA |
| 3:00pm – 3:50pm | Concierge Benefit Managers Offering Differentiated Oncology Experiences for Patients Moderator: Lalan Wilfong, MD, Senior Vice President Value Based Care, Thyme Care Faculty: Rebecca Miksad, MD, MMS, MPH, Chief Medical Officer, Color Randy K. Hawkins, MD, FACHE, Chief Medical Officer, Transcarent Pete Scruggs, Founder, benefitSMART Nicki MacManus, SVP, General Manager Cancer Care Direct, Employee Direct Healthcare Deirdre Saulet, PhD, Market VP, Oncology, Carrum Health |
| 3:00pm – 3:50pm | Multiple Myeloma: An Ideal model for Establishing the Principles of Value-Based Payments Moderator: Tony Blau, MD, Founder & CEO, All4Cure Faculty: Nick Sarlis, MD, PhD, FACP, Chief Medical Office, CLEARA C. Ola Landgren, MD, PhD, Professor of Medicine, Chief of Myeloma Division, University of Miami Sam Stolpe, MPH, PharmD, Head of Healthcare Quality Strategy, Johnson & Johnson Brian Decker, MBA, President & CEO, EMOL Health Subrat Roychoudhary, MS, MBA, Value and Access Strategy Head for Cell Therapy Portfolio – US Market, Bristol Myers Squibb |
| 3:00pm – 3:50pm | Drug Aggregators and Group Purchasing Organizations How Will They Remain Relative in the Value Equation Moderator: Steve O’Malley, President, Petauri Advisor Faculty: Rick Lozano, SVP, Specialty GPOs, Cencora Tim Boozan, VP of GPO Business Development, VP, GPO Operations, McKesson Ginger Ertel, PharmD, MBA, VP, Pharmacy Member Services, Vizient Thom Cohn, MS, Chief Strategy Officer, Asembia |
| 4:00pm – 4:50pm | Value-Based Enterprise: A Case Study of Hospital System and Community Practice Collaboration Moderator: Daniel Frier, Esq., Founding Partner, Frier Levitt Faculty: Bill Robertson, Multicare Sibel Blau, MD, President & CEO, ONCare Alliance/Exigent Research Jason Parks, President, MultiCare Capital Partners |
| 4:00pm – 4:50pm | Enhancing Payer Quality Metrics through Oncology Screening Moderator: Stan Skrzypzcak, MS, MBA, Managing Partner, 5Prime Life Science Consulting, Inc. Faculty: Kathryn Lang, MD, MRCP(UK), FRCPath, RWE and Clinical Research Consultant Mark Hiatt, MD, MBA, MS, Senior Vice President of Market Access & Strategy, BostonGene; Chief Medical Officer, RadSite Peter Bach, MD, Chief Medical Officer, DELFI Diagnostics Donna Polizio, MSOL, Global Head of Market Access, Bionano |
| 4:00pm – 4:50pm | Value-Based Cancer Care and ERISA Fiduciary Duties: How Self-Insured Employer Plans Can Navigate Regulatory, Quality, and Cost Concerns While Delivering Meaningful Benefits for Their Employees Moderator: Christine Worthen, Epstein, Becker and Green Faculty: Justin Bekelman, MD, CEO, Daymark Health Jonathan Rhodes, VP, Healthcare Foundry Orriel Richardson, Head of Policy & Advocacy, Morgan Health JPMorganChase |
| 4:00pm – 4:50pm | Pathways for Social Needs Assessment and Care Moderator: Joel White, CEO, Horizon Government Affairs Faculty: Todd Goldstein, MHA, Memorial Sloan Kettering Cancer Center Alan Balch, CEO, Patient Advocacy Foundation William Rogers, MD, FACEP, Chief Medical Officer, Applied Policy Norm Shore, CEO, Patient Discovery |
| 5:00pm – 5:50pm | Cancer Care Outlook from the Trades Moderator: Marci Mutti, Senior Vice President/Head of Advisory, ADVI Health Faculty: John O’Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council; Former Senior Advisor to Secretary of US Department Health and Human Services Andrew Cosgrove, Senior Director, BIO Erica Cischke, MPH, Vice President, Government Affairs, Alliance for Regenerative Medicine |
| 5:00pm – 5:50pm | Unintended Consequences? Will JCAs Have an Impact Beyond Europe and What Does this Mean for Manufacturers, Payers, and Patients in the USA? Moderator: Richard Macaulay, PhD, Senior Vice President, Global Pricing & Access Strategy, Precision AQ Faculty: Beth Hamilton, VP, Global Oncology Market Access and Pricing, AstraZeneca Annette Powers, PharmD, MBA, Senior Vice President, Global Market Access and HEOR, Bristol Myers Squibb Andrew Cournoyer, RPh, MBA, SVP, Director, Precision AQ |
| 5:00pm – 5:50pm | Navigating the 340B Program Amidst Policy Shifts Moderator: Sherri Faber, RPh, MHA, President & CEO, 340B Compliance Partners Faculty: Ted Slafsky, MPP, Publisher & CEO, 340B Report Shannon Burger, MBA, CPA, CEO, Cempa Community Care Mark Ogunsusi, Esq., PharmD, JD, Associate, Powers Pyles Sutter & Verville PC Mesfin Tegenu, CEO, RxParadigm Jim Donohue, MBA, Partner, ECG Management Consultants |
| 5:00pm – 5:50pm | Reimbursement: Get Ready for 2025 Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Maddi Davidson, Principal of Market Access, Avalere Steve O’Malley, President, Petauri Advisors Lavi Kwiatkowsky, Founder & CEO, Canopy Roberta Buell, Principal, onPoint Oncology |
| 6:00pm – 7:00pm | Cancer Research and the Road Ahead Moderator: Rob Butcher, President & CEO, Swim Across America Faculty: Steven Rosen, MD, FACP, FASCO, FAIMBE, Provost and Chief Scientific Officer, City of Hope Nancy Daly, MS, MPH, CEO, Conquer Cancer Andrea Cercek, MD, Associate Attending Physician, Memorial Sloan Kettering Cancer Center |
| 7:00pm –8:00pm | Reception Honoring Swim Across America surpassing the $120m Funding Ceiling for Cancer Research in 2023 Photo Opportunity with the Past, Current and Future Members of USA Olympic Swimming Team |
Friday, October 18
Summit Day 3
Summit Day 3
| 7:30am – 8:00am | BREAKFAST |
| 7:00am – 7:50am | Breaking the Value-Based Gridlock: Can Technology Tame the VBA Beast in Oncology? Moderator: Real Endpoints Faculty: Domenick Fanelli, PhD, Executive Director, Portfolio Contract Strategy, AstraZeneca Scott Kornhauser, Executive VP, KlearTrust Heidi Toretto, MBA, MS, Executive Director, Value Access & Operations, COEUS |
| 7:00am – 7:50am | Opportunities and Challenges in Value-Based Payment Models in Radiology and Radiation Oncology Services Moderator: Join Y. Luh MD, FACP, FACR, FASTRO, Radiation Oncologist, Providence Health Faculty: Lauren Nicola, MD, FACR, CEO, Triad Radiology Associates Anne Hubbard, MBA, Director of Health Policy, American Society for Radiation Oncology (ASTRO) Sameer Keole, MD, FASTRO, MAYO Clinic, President-elect, ASTRO Frank Lexa, MD, MBA, FACR, President and Vice Chairman, Department of Radiology, University of Pittsburgh Al Lawson, MD, SVP Radiation Oncology Services, Tennessee Oncology Jeremy Castle, MBA, Chief Operations Officer, The Oncology Institute for Hope and Innovation |
| 7:00am – 7:50am | Oncology Protocols & Standardization Beyond Therapy Selection Moderator: Matthew Cunningham, Partner, The Dedham Group Faculty: Shamim Patel, MS, RHIA, Executive Director, Health Information Technology, Novartis Robert Daly, MD, MBA, Thoracic Oncologist, Memorial Sloan Kettering Mick Correll, President, Genospace |
| 8:00am __ 8:50am | Integrating Precision Medicine Data into Real-World Clinical Pathways Moderator: Lalan Wilfong, Senior Vice President Value Based Care, Thyme Care Faculty: Lucy Langer, MS, MD, National Medical Director, Oncology and Genomics, UnitedHealthcare Sibel Blau, MD, President & CEO, ONCare Alliance/Exigent Research Lucio Gordan, MD, President & Managing Physician, Florida Cancer Specialists John Migliano, MD, MBA, Senior Medical Officer, The Oncology Institute |
| 8:00am __ 8:50am | The Future of Clinical Pathways in Oncology to Ensure Quality Access to Care Moderator: Jordan Johnson, MSHA, Founder, Bridge Oncology Faculty: Arpit Chhabra, MD, Co-Founder, Bridge Oncology Andrew Norden, MD, MPH, Chief Medical Officer, OncoHealth Susan Niskey Popp, MBA, MS, FACHE, CIM, CTRI, Senior Vice President, Joint Ventures and Radiation & Imaging, McKesson Deirdre Saulet, PhD, Market VP, Oncology, Carrum Health |
| 8:00am __ 8:50am | Unlocking Patient Care Through AI: Reimagining Specialty Drug Support Programs Moderator: Ankit Jain, CEO, Infinitus AI Faculty: Nirav Shah, MBA, Chief Revenue Officer, OneOncology Scott Kornhauser, EVP, KlearTrust Bryan Bloom, National Director of Sales, TailorMed |
| 8:00am __ 8:50am | Survivorship Moderator: Steven Peskin, MD, MBA, MACP, Associate Clinical Professor, Robert Wood Johnson School of Medicine Faculty: Hil Moss, MBA, Co-Founder & CEO, OncoveryCare Nisha Bhalla, CEO & Founder, Sweeten Health Nabeel Kaukab, CEO & Co-Founder, Phamily |
| 9:00am __ 9:50am | Can We Transform Healthcare from Within? Moderator: Basit Chaudhry, MD, PhD, Founder, Tuple Health Faculty: Muna Tuna, US Market Pricing and Reimbursement Leader, Ernest & Young, LLP Lucio Gordan, MD, President & Managing Physician, Florida Cancer Specialists Andres Rodriguez, MBA, Director, Public Payer Strategy, Biogen Mike Fazio, Head of Value-Based Care, Navista Anand Vishwarupe, Managing Partner, ZS Associates Andrew Cournoyer, RPh, MBA, SVP, Director – Access Experience Team, PRECISION AQ |
| 9:00am __ 9:50am | Care Management: If It’s So Good, Why Aren’t We Doing It? Moderator: Lavi Kwiatkowsky, Founder & CEO, Canopy Faculty: Kathryn Paliotta, RN, Vice President of Patient Communications, New York Cancer & Blood Specialists Debra Patt, MD, PhD, MBA, Executive Vice President, Policy and Strategic Initiatives, Texas Oncology Susan Sabo-Wagner, Vice President of Clinical Innovation, American Oncology Network (AON) |
| 9:00am __ 9:50am | The Role of AI for Value and Outcomes in Oncology Care Moderator: Jon Hamrick, Partner, Curatio Faculty: Stephen Speicher, MD, MS, Head of Healthcare Quality and Patient Safety, Flatiron Health Mike Robbins, Chief Marketing Officer, Consequient Solutions Frank Scimeca, PharmD, MBA, BCOP, VP, Pharmacy Services, Florida Cancer Specialists & Research Institute Mark Alwardt, VP, Specialty Pharmacy Solutions, McKesson |
| 9:00am __ 9:50am | Practice Transparency Laws and Future Moderator: Alti Rahman, MHA, MBA, CSSBB, Chief Strategy and Innovation Officer, American Oncology Network, LLC (AON) Faculty: Deirdre Saulet, PhD, Market VP, Oncology, Carrum Health Chris O’Dell, SVP of Market Solutions, Turquoise Health Megan Herber, Principal, Faegre Drinker Consulting |
| 10:00am __ 10:50am | Transition to Value – Pharma Update Moderator: William McGivney, PhD, Managing Partner, McGivney Global Advisors Faculty: Jeff Davis, Executive Director National Channel, AstraZeneca Todd Grisco, VP, Market Access Strategic Accounts, Bristol Myers Squibb Nancy Bell, Vice President, Head of Market Access Scott Howell, MD, Former US Chief Strategy Officer, Novartis; Co-founder, Synapse Sciences Gene Trogan, PhD, Director, Value & Access Marketing – Oncology, Boehringer Ingelheim |
| 10:00am – 10:50am | After We Tell “You Have Cancer” Next They Tell You “We Don’t Have the Drug for You” the Drug Shortage Reality Moderator: Omar Hafez, SVP and Practice Director of Market Access, Avalere Faculty: Barry Brooks, MD, MBA, Medical Director GPO Services McKesson Specialty Health Scott Biggs, Director, Supplier Services, IQVIA Lindsey Thomas, SVP, Marketing, Fresenius Kabi |
| 10:00am – 10:50am | Designing Novel Drug Distribution Channels and Improving Patient Access Moderator: Alerie Stiles, SVP Commercial Growth, House Rx Faculty: Jason Noto, MBA, SVP, US Market Access, Aveo Oncology Jay Seemann, VP, Market Access & Value: US & Shared Services (Ex China), BeiGene Yale Podnos, MD, MPH, FACS, Chief Medical Officer, The Oncology Institute Christie Smith, PharmD, MBA, VP, Specialty Payer Strategy, Cencora Pam Muia, MBA, Senior Director, Trade and Distribution, SpringWorks Therapeutics |
| 10:00am – 10:50am | Pediatric Cancer Care – Optimize Research and Demonstrate Outcomes Moderator: Jon Hamrick, Partner, Curatio Scientia Advisors Faculty: Robyn Gartrell, MD, MS, Assistant Professor in Pediatrics and Oncology, The Johns Hopkins University School of Medicine Andrew Kung, MD, PhD, Chair of Pediatrics, Memorial Sloan Kettering Cancer Center Stephen Speicher, MD, MS, Head of Healthcare Quality and Patient Safety, Flatiron Health |
| 11:00am – 11:50am | Patient Advocacy: Differentiating Our Work in an Era of Value, Technology, and Competition Moderator: Elizabeth F. Franklin, PhD, MSW, Head US Public Affairs and Patient Advocacy, Sanofi Faculty: Christine Verini, RPH, CEO, CancerCare Rose Gerber, MS, Director Patient Advocacy and Education, COA Kevin Hagan, President & CEO, PAN Foundation Lisa Lacasse, MBA, President, American Cancer Society Cancer Action Network Ken Trogdon, President, HarborPath |
| 11:00am – 11:50am | Disparities and Real Solutions Moderator: Sybil Green, JD, RPh, MHA, Diversity and Inclusion Officer, American Society of Clinical Oncology Faculty: Ben Stormer, Chief Commercia Officer, Annexus Health Norm Shore, CEO, Patient Discovery |
| 11:00am – 11:50am | Surgery and Role in Value Based Care Paradigms Moderator: Deirdre Saulet, PhD, Market VP, Oncology, Carrum Health Faculty: Yale Podnos, MD, MPH, FACS, Chief Medical Officer, The Oncology Institute Casey Allen, MD, Div. Surgical Oncology, Institute of Surgery, Allegheny Heath Network Steven Brower, MD, FACS, Emeritus Director, Englewood Health Cancer Center, Director, Regional Cancer Network, Englewood Health, Chief of Hepatic/Pancreatic/Biliary Surgery and Surgical Oncology, Englewood Health, Professor of Surgery HMHSOM |
| 11:00am – 11:50am | Contemporaneous Real-World Data to Guide Research and Value-Based Contracting Moderator: Stan Skrzpczak, MS, MBA, Managing Partner, 5Prime Life Science Consulting, Inc. Faculty: Mark Lee, MD, CEO, NPower Sibel Blau, MD, President & CEO, ONCare Alliance/Exigent Research Yale Podnos, MD, MPH, FACS, Chief Medical Officer, The Oncology Institute Stan Kachnowski, PhD, MPA, Director, Digital Health Program, Columbia Business School Scotty Pepper, MSM, VP Operations, Population Health, Integra Connect |
